Food News and Research

RSS

Einstein College receives grant to develop stem cell-based therapies

Scientists at Albert Einstein College of Medicine of Yeshiva University have received a five-year, $10.8 million grant to develop stem cell-based therapies that could be used to mitigate radiation-induced gastrointestinal syndrome - part of acute radiation syndrome (ARS) - for military personnel, first responders and the general public. The Einstein research, funded by the federal Centers for Medical Countermeasures Against Radiation, is part of a program coordinated by the National Institute of Allergy and Infectious Diseases.

12 Aug 2010

Smoking rates continue to fall in Japan

Japan has set a world record with the 15th consecutive year of low smoking rates according to a nationwide survey released Wednesday by Japan Tobacco Inc.

11 Aug 2010

Advanced Life Sciences second-quarter net loss decreases to $2.1 million

11 Aug 2010

Shire announces divestiture of Daytrana to Noven Pharmaceuticals

Shire plc, the global specialty biopharmaceutical company, announced the divestiture of Daytrana (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc. Daytrana, which is approved and marketed in the US for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents, will continue to be available for patients through Noven.

11 Aug 2010

Sugary drinks do not promote weight gain in overweight women: Research

New research from Queen Margaret University, Edinburgh, shows that sugary drinks, consumed in moderate quantities, do not promote weight gain, carbohydrate craving or adverse mood effects in overweight women when they do not know what they are drinking.

11 Aug 2010

Serving breakfast in classroom overcomes School Breakfast challenges: FRAC

Serving breakfast in the classroom instead of in the cafeteria is among the best options to overcome challenges such as time constraints and staffing issues when offering School Breakfast. According to the Food Research and Action Center's School Breakfast Scorecard for 2008-2009, districts using breakfast in the classroom have the highest participation rates.

11 Aug 2010

Depomed announces SPA agreement with FDA for Serada Phase 3 trial for menopausal hot flashes

Depomed, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration regarding a Special Protocol Assessment on the design and analysis of Breeze 3, a Phase 3 trial evaluating Serada® (extended release gabapentin tablets) for menopausal hot flashes.

11 Aug 2010

Temperature increases could slow rice production, study says

A study published online Monday in Proceedings of the National Academy of Sciences found that anticipated temperature increases "could slow the growth of rice production unless farmers adapt by changing management practices and switch to more heat-tolerant varieties," Reuters reports (Fogarty, 8/10).

11 Aug 2010

NKTreg white blood cells migrate into liver, suppress immune responses: Research

After a transplant - and to assure that the new organ is not rejected - patients are put on life-long therapy to suppress their immune system, which, nevertheless, needs to be left intact enough to be able to defend the body against all kinds of disease. A tricky balance as the many rejected organs attest. But a discovery by Maria Monteiro and Luis Graça, two Portuguese scientists, could change all this, at least for the liver.

11 Aug 2010

First complete sample-to-result, point-of-care DNA testing system for personalized medicine

Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, today announced the availability of the Spartan RX, the first complete sample-to-result, point-of-care DNA testing system for personalized medicine. The non-invasive and easy-to-use system provides automated results in one hour, enabling physicians to tailor treatments based on a patient's genotype faster than ever before.

11 Aug 2010

Bluhm Cardiovascular Institute implants two Heartware ventricular assist devices

The Bluhm Cardiovascular Institute of Northwestern Memorial Hospital recently implanted a patient with two of the smallest experimental ventricular assist devices (VADs) currently available for study in humans. VADs are designed to assist either the right (RVAD) or left (LVAD) ventricle, or both (BiVAD) at once. This is the first time that two Heartware VADs have been implanted in the left and right ventricles anywhere in North America—a "game changer" in the realm of heart assist devices according to Patrick M. McCarthy, MD, chief of the hospital's division of cardiac surgery and director of the hospital's Bluhm Cardiovascular Institute.

11 Aug 2010

Ancient immunoglobulin study explains evolution of human intestinal immune responses

A study at the University of Pennsylvania School of Veterinary Medicine has identified the function of one of the earliest antibodies in the animal kingdom, an ancient immunoglobulin that helps explain the evolution of human intestinal immune responses. It was discovered to play a predominant role in the guts of fish and paves the way for a better understanding of human gut immunity as well as for safer, healthier approaches to keeping fish from pathogen infections. The findings appear in the online version of Nature Immunology and will be featured on the cover of the September issue.

11 Aug 2010

Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize Eplerenone

Sinobiopharma, Inc., an innovative biopharmaceutical products company with primary operations in China, today announced that the Company, through its wholly-owned subsidiary Dong Ying Pharmaceutical Co., Ltd., has signed an agreement with Jiangsu Lianhuan Pharmaceuticals Co., Ltd. to co-develop, manufacture and commercialize Eplerenone, a therapeutic agent formulated to treat high blood pressure and vascular diseases.

11 Aug 2010

Jazz Pharmaceuticals second-quarter net product sales increase 49% to $39.5 million

Jazz Pharmaceuticals, Inc. announced financial results for the second quarter ended June 30, 2010 and updated financial guidance for 2010. The company's updated financial guidance reflects higher expected sales of XYREM® (sodium oxybate) and the effects of recent financing activities.

11 Aug 2010

China Nepstar Chain Drugstore second-quarter revenue increases 5.8% to RMB565 million

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the quarter ended June 30, 2010.

11 Aug 2010

House returns from recess to vote on extra Medicaid help for states

The House will vote today on a package that includes $16.1 billion in extra federal Medicaid money for states who say they need to close budget gaps.

11 Aug 2010

Enriched breakfast re-energizes children's morning rituals and boosts learning potential

As the lazy days of summer vacation begin to come to a close, it's time to start thinking about re-formulating and re-energizing morning rituals that can help boost your child's learning potential.

11 Aug 2010

Advanced Life Sciences reaches SPA agreement with FDA for Restanza Phase 3 study

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.

11 Aug 2010

NovoSeven RT in 8 mg vial for hemophilia A or B with inhibitors receives FDA approval

Novo Nordisk announced today that the U.S. Food and Drug Administration has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making the hemophilia A or B with inhibitors treatment available in 1, 2, 5 and 8 mg vials. The 8 mg vial allows a rapid initiation and administration of this medication for those patients who need a larger dose. In addition, FDA has also approved the extension of shelf life for all vial sizes from 24 months to 36 months at room temperature (at or below 77 degrees Fahrenheit).

11 Aug 2010

Scientists identify chemical system effective in cocaine-addiction cure

UT Southwestern Medical Center researchers have identified a chemical system in the brain that reacts differently in cocaine addicts, findings that could result in new treatment options for individuals addicted to the drug."We found that the amount of blood flow in areas of the brain known to be involved in the rewarding effects of cocaine and craving was different in cocaine addicts, compared with healthy subjects," said Dr. Bryon Adinoff, professor of psychiatry at UT Southwestern and lead author of a study that appeared in Neuropsychopharmacology. "Now we have a new target for pharmacologic intervention."

11 Aug 2010

Food News and Research

Einstein College receives grant to develop stem cell-based therapies

Smoking rates continue to fall in Japan

Advanced Life Sciences second-quarter net loss decreases to $2.1 million

Shire announces divestiture of Daytrana to Noven Pharmaceuticals

Sugary drinks do not promote weight gain in overweight women: Research

Serving breakfast in classroom overcomes School Breakfast challenges: FRAC

Depomed announces SPA agreement with FDA for Serada Phase 3 trial for menopausal hot flashes

Temperature increases could slow rice production, study says

NKTreg white blood cells migrate into liver, suppress immune responses: Research

First complete sample-to-result, point-of-care DNA testing system for personalized medicine

Bluhm Cardiovascular Institute implants two Heartware ventricular assist devices

Ancient immunoglobulin study explains evolution of human intestinal immune responses

Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize Eplerenone

Jazz Pharmaceuticals second-quarter net product sales increase 49% to $39.5 million

China Nepstar Chain Drugstore second-quarter revenue increases 5.8% to RMB565 million

House returns from recess to vote on extra Medicaid help for states

Enriched breakfast re-energizes children's morning rituals and boosts learning potential

Advanced Life Sciences reaches SPA agreement with FDA for Restanza Phase 3 study

NovoSeven RT in 8 mg vial for hemophilia A or B with inhibitors receives FDA approval

Scientists identify chemical system effective in cocaine-addiction cure

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News